NDC 0456-2402 – Saphris

Asenapine Maleate 2.5 mg/1 · Tablet · Sublingual

Human Prescription Drug 1 recall

Product NDC0456-2402

Product details

Brand name
Saphris
Generic name
Asenapine Maleate
Labeler
Allergan, Inc.
Dosage form
Tablet
Route
Sublingual
Marketing category
NDA · NDA022117
Marketed since
December 30, 2014
Listing expires
December 31, 2026
Pharmacologic class
Atypical Antipsychotic

Active ingredients

Uses, dosage, side effects and warnings for Saphris →

Package NDC codes (3)

Package NDCDescriptionSince
0456-2402-10 sample1 CASE in 1 CARTON (0456-2402-10) / 1 BLISTER PACK in 1 CASE / 10 TABLET in 1 BLISTER PACKDec 30, 2014
0456-2402-606 CASE in 1 CARTON (0456-2402-60) / 1 BLISTER PACK in 1 CASE (0456-2402-06) / 10 TABLET in 1 BLISTER PACKDec 30, 2014
0456-2402-6310 BLISTER PACK in 1 CARTON (0456-2402-63) / 10 TABLET in 1 BLISTER PACK (0456-2402-11)Dec 30, 2014

Recalls mentioning this NDC

Other Saphris products